Calprotectin Level | 0–50 | 51–100 | 101–200 | 201–500 | 501–1000 | 1001–1800 |
---|---|---|---|---|---|---|
Total patients | 673 | 162 | 120 | 95 | 27 | 36 |
Not referred | (71%)480 | (41%)67 | (21%)25 | (17%)16 | (8%) 2 | (25%) 9 |
Referred | (29%)193 | (59%)95 | (79%)95 | (83%)79 | (93%)25 | (75%)27 |
Not scoped | (66%)128 | (47%)45 | (54%)51 | (43%)34 | (16%) 4 | (15%) 4 |
Scoped | (34%) 65 | (31%)50 | (46%)44 | (57%)45 | (84%)21 | (86%)23 |
Normal | (65%) 42 | (56%)28 | (72%)32 | (40%)18 | (19%) 4 | (13%) 3 |
Non-IBD | (35%)23 | (44%)22 | (18%)8 | (31%)14 | (29%)6 | (4%)1 |
IBD | (0%) 0 | (0%) 0 | (9%) 4 | (29%)13 | (52%)11 | (83%)19 |